Dec 8, 2023
January 26, 2025
This week’s newsletter included:
- BioUtah Podcast Series: “Life Sciences in Action” with James McCullough of Renalytix
- Sera Prognostics Announces Primary Endpoint Criteria Met in Pivotal PRIME Study Interim Look
- Merit Medical Announces Pricing of Upsized Private Offering of $650 Million of 3.00% Convertible Senior Notes Due 2029
- Culmination Bio Raises $10 Million from Amgen Ventures and Merck Global Health Innovation Fund
- RxCell Announces $4.6 Million Investment from DMR Global Venture and Regenosis
- Utah Life Sciences Companies Represent at MEDICA 2023
- Utah Tech Atwood Innovation Plaza: A Space to Grow Your Start-Up
- Utah Business Announces Utah’s Best Companies to Work For in 2023
- Edwards Lifesciences to Spin Off Critical Care Unit
- BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device
- 100 Companies Championing Women
Featured New Member: Polsinelli
Recent News
- Improving Women’s Health: MobileODT Joins Liger Medical
- Wasatch Health Announces Structured Capital Fund
- Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas, Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains
- Nestmedic Selects Curavit Clinical Research as U.S. CRO Partner for Pioneering Prenatal Monitoring Trial
- Microvascular Therapeutics Celebrates Major Achievements at ASE 2025 Scientific Sessions
- BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)